SMARCA4 and neoplasm: These data show that the expression (= combination of the intensity of immunostaining and amount of immunopositive tumor areas) of SMARCA4 and SMARCE1 was heterogeneous in GC, including “gray scale” and “black‐and‐white” immunostaining patterns (Figure 2).